Gensight Biologics SA
PAR:SIGHT
Gensight Biologics SA
PAR:SIGHT
Price:
0.1172
EUR
-1.84%
Market Closed
Market Cap:
€27.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Gensight Biologics SA
PAR:SIGHT
|
FR |
|
Wiluna Mining Corporation Ltd
ASX:WMC
|
AU |
|
K
|
KC Feed Co Ltd
KOSDAQ:025880
|
KR |
|
U
|
Ubiquitech Software Corp
OTC:UBQU
|
US |
|
Minco Silver Corp
OTC:MISVF
|
CA |
|
M
|
Masco Corp
XMUN:MSQ
|
US |
|
S
|
Smartstop Self Storage Reit Inc
OTC:STSFF
|
US |
Wall St Price Targets
SIGHT Price Targets Summary
Gensight Biologics SA
Gensight Biologics SA
Wall Street analysts forecast SIGHT stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for SIGHT is 0.3111 EUR with a low forecast of 0.2121 EUR and a high forecast of 0.42 EUR.
Lowest Forecast
Price Target
0.2121
EUR
81% Upside
Average Forecast
Price Target
0.3111
EUR
165% Upside
Highest Forecast
Price Target
0.42
EUR
258% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SIGHT's stock price target?
Price Target
0.3111
EUR
0.3111
EUR
According to Wall Street analysts, the average 1-year price target for SIGHT is 0.3111 EUR with a low forecast of 0.2121 EUR and a high forecast of 0.42 EUR.
What is the Revenue forecast for Gensight Biologics SA?
Projected CAGR
3 452%
3 452%
The compound annual growth rate for Revenue over the next 3 years is 3 452%.
